78 services · researched 2026-08-14
Real companies, sourced facts. Each review records what the provider publishes, what it leaves out, and what the total actually comes to once the membership is added to the medication.
58 services. Prices are in US dollars and are only comparable within this table.
| Provider | Model | Supply | Lowest published | Disclosure | Flags |
|---|---|---|---|---|---|
| OrderlyMeds | Telehealth platform | Brand-name and compounded | $74/mo | 9/13 | ■ FDA action |
| Embody | Telehealth platform | Compounded | $79/mo | 10/13 | — |
| Nurx | Telehealth platform | Brand-name | $94/mo | 10/13 | — |
| Cora Health | Telehealth platform | Compounded | $99/mo | 10/13 | — |
| CoreAge Rx | Telehealth platform | Compounded | $99/mo | 10/13 | — |
| AgelessRx | Telehealth platform | Compounded | $99/mo | 9/13 | — |
| Found | Telehealth platform | Brand-name and compounded | $99/mo | 7/13 | — |
| Wisp | Telehealth platform | Brand-name | $99/mo | 4/13 | — |
| 24hrDoc | Telehealth platform | Compounded | $129/mo | 9/13 | — |
| Fifty 410 | Telehealth platform | Compounded | $133/mo | 10/13 | ■ FDA action |
| Bodybuilding Health+ | Telehealth platform | Compounded | $139/mo | 8/13 | — |
| Mochi Health | Telehealth platform | Brand-name and compounded | $139/mo | 8/13 | — |
| NovoCare Pharmacy (Wegovy) | Manufacturer direct | Brand-name | $149/mo | 9/13 | — |
| Sesame | Clinician marketplace | Brand-name | $149/mo | 8/13 | — |
| Gala Health | Telehealth platform | Brand-name and compounded | $149/mo | 7/13 | — |
| Walgreens Weight Management | Retail pharmacy | Brand-name | $149/mo | 9/13 | — |
| CVS MinuteClinic | Retail pharmacy | Brand-name | $149/mo | 9/13 | — |
| Amazon One Medical | Telehealth platform | Brand-name | $149/mo | 8/13 | — |
| Zealthy | Telehealth platform | Brand-name and compounded | $151/mo | 7/13 | — |
| Shed | Telehealth platform | Brand-name and compounded | $159/mo | 7/13 | — |
| Brello Health | Telehealth platform | Compounded | $166/mo | 9/13 | — |
| Alloy Weight Care | Telehealth platform | Compounded | $169/mo | 9/13 | — |
| Noom (GLP-1 Microdose) | Telehealth platform | Compounded | $179/mo | 9/13 | — |
| Calibrate | Telehealth platform | Brand-name | $199/mo | 7/13 | — |
| Ro (Ro Body) | Telehealth platform | Brand-name | $223/mo | 8/13 | — |
| Ivím Health | Telehealth platform | Compounded | $224/mo | 8/13 | — |
| Shapely | Telehealth platform | Brand-name and compounded | $238/mo | 10/13 | — |
| Lemonaid Health | Telehealth platform | Brand-name and compounded | $248/mo | 9/13 | — |
| Hers | Telehealth platform | Brand-name | $298/mo | 4/13 | ■ FDA + FTC action |
| LillyDirect (Zepbound) | Manufacturer direct | Brand-name | $299/mo | 9/13 | — |
| Maven Clinic | Telehealth platform | Brand-name | $299/mo | 8/13 | — |
| LifeMD | Telehealth platform | Brand-name and compounded | $348/mo | 12/13 | — |
| Levity | Telehealth platform | Brand-name | $1199/mo | 8/13 | — |
| WeightWatchers Clinic | Telehealth platform | Brand-name | Not published | 8/13 | — |
| Teladoc Health | Employer / health-plan benefit | Brand-name | Not published | 5/13 | — |
| Raeliva | Telehealth platform | Compounded | Not published | 9/13 | — |
| Indigo Health | Telehealth platform | Brand-name | Not published | 8/13 | — |
| Henry Meds | Telehealth platform | Compounded | Not published | 10/13 | — |
| Doctronic | Telehealth platform | Brand-name | Not published | 8/13 | — |
| Brightmeds | Telehealth platform | Brand-name and compounded | Not published | 8/13 | — |
| Klinic | Telehealth platform | Brand-name and compounded | Not published | 7/13 | — |
| Hello Dose | Telehealth platform | Compounded | Not published | 6/13 | — |
| VIOS Compounding Pharmacy | Compounding pharmacy | Compounded | Not published | 7/13 | — |
| Form Health | Telehealth platform | Brand-name | Not published | 6/13 | — |
| knownwell | Telehealth platform | Brand-name | Not published | 7/13 | — |
| Omada Health | Employer / health-plan benefit | No medication — programme only | Not published | 7/13 | — |
| Hone Health | Telehealth platform | Compounded | Not published | 9/13 | — |
| Aspire Health | Telehealth platform | Compounded | Not published | 10/13 | — |
| InjectCo | Telehealth platform | Compounded | Not published | 2/13 | — |
| Health Meets Wellness | Telehealth platform | Brand-name | Not published | 4/13 | — |
| Remedy Meds | Telehealth platform | Brand-name and compounded | Not published | 10/13 | ■ FDA action |
| Strut Health | Telehealth platform | Compounded | Not published | 5/13 | ■ FDA action |
| Empower Pharmacy | Compounding pharmacy | Compounded | Not published | 7/13 | ■ FDA action |
| Virta Health | Lifestyle programme | No medication — programme only | Not published | 6/13 | — |
| Klarity Health | Clinician marketplace | Brand-name | Not published | 7/13 | — |
| CallOnDoc | Telehealth platform | Brand-name and compounded | Not published | 8/13 | — |
| 9amHealth | Employer / health-plan benefit | Brand-name | Not published | 6/13 | — |
| PlushCare | Telehealth platform | Brand-name | Not published | 9/13 | — |
20 services. Prices are in pounds sterling and are only comparable within this table. Only 10% of them publish a usable price, against 57% in the US — and that is mostly the law rather than evasion, since advertising a prescription-only medicine to the public is prohibited here. Why UK pages tell you less.
| Provider | Model | Supply | Lowest published | Disclosure | Flags |
|---|---|---|---|---|---|
| SheMed | Telehealth platform | Brand-name | £59/mo | 10/13 | — |
| Juniper (UK) | Telehealth platform | Brand-name | £164/mo | 9/13 | — |
| Numan | Telehealth platform | Brand-name | Not published | 7/13 | — |
| Voy | Telehealth platform | Brand-name | Not published | 5/13 | — |
| Oviva | Lifestyle programme | Brand-name | Not published | 8/13 | — |
| Second Nature | Lifestyle programme | Brand-name | Not published | 6/13 | — |
| Yazen | Telehealth platform | Brand-name | Not published | 6/13 | — |
| Medino | Retail pharmacy | Brand-name | Not published | 3/13 | — |
| Prescription Doctor | Retail pharmacy | Brand-name | Not published | 7/13 | — |
| The Independent Pharmacy | Retail pharmacy | Brand-name | Not published | 8/13 | — |
| PrivateDoc | Telehealth platform | Brand-name | Not published | 5/13 | — |
| Boots Online Doctor | Retail pharmacy | Brand-name | Not published | 7/13 | — |
| Rightangled | Telehealth platform | Brand-name | Not published | 7/13 | — |
| UK Meds | Retail pharmacy | Brand-name | Not published | 7/13 | — |
| Chemist Click | Retail pharmacy | Brand-name | Not published | 6/13 | — |
| Weight Loss Clinic UK | Telehealth platform | Brand-name | Not published | 6/13 | — |
| MyPharmacy | Retail pharmacy | Brand-name | Not published | 4/13 | — |
| Pharmica | Retail pharmacy | Brand-name | Not published | 7/13 | — |
| Pharmacy Planet | Retail pharmacy | Brand-name | Not published | 7/13 | — |
| PostMyMeds | Retail pharmacy | Brand-name | Not published | 7/13 | — |
“Lowest published” is the cheapest recurring monthly figure we could verify, membership included where one is mandatory. It is not the price of a maintenance dose, and it is only comparable within a single market. “Disclosure” counts how many of thirteen standard review items the provider publishes. Market scope: Primarily the United States, with a UK section. US prices are USD and refer to the FDA; UK prices are GBP and refer to the MHRA. Every provider page states which market it covers.
The manufacturer selling its own brand-name tirzepatide direct to self-paying patients, at published per-dose prices. It does not prescribe — you bring the prescription.
Novo Nordisk’s own pharmacy channel for brand-name semaglutide, including the Wegovy pill, with self-pay prices published per form and dose.
The most completely published price list we found: a $49/month membership with every medication priced separately and openly, brand-name and compounded side by side.
A brand-name-only programme built around getting your insurance to pay, with a low introductory membership and an insurance coordinator doing the paperwork.
A clinician marketplace rather than a subscription: you pick the provider, labs are included, and it deliberately does not offer compounded semaglutide.
Reached mainly through an employer or health plan rather than bought directly, and the least price-transparent service we looked at.
The lowest published compounded medication price we verified — but only once you add the $99 membership, and it is unavailable in seven states.
Compounded semaglutide from $149/month plus a $74.99 membership, and one of the few to confirm HSA/FSA cards work.
Compounded tirzepatide sold as a prepaid 3-month block — $499 charged today — with an unusually specific refund clause.
The cheapest starter price we have verified at $74/month — and it doubles at month four, which the page states but the headline does not.
Compounded GLP-1s from $79 a month with free expedited delivery, HSA/FSA accepted, and a cancellation rule tied to the next shipment.
Flat $179 a month for compounded tirzepatide at every dose — one of the few services where titrating up does not raise the bill.
No membership fee, medication included, the same price at every dose, and HSA/FSA accepted — but no price published anywhere on the page.
The widest GLP-1 menu we found — injections, drops, lozenges, pills, and both brand names — behind a results guarantee.
Brand-name only, from $149/month self-pay or as little as $25 with coverage, wrapped in metabolic and hormone specialist care.
A health-system service rather than a startup: $99 without insurance, no membership, most insurances accepted, and the prescription goes to your own pharmacy.
Publishes a dose-by-dose price ladder in milligrams and ships refrigerated overnight — unusually concrete for a compounded service.
All-inclusive plan pricing with no hidden fees, a named cancellation route — and a multi-month clause that can leave you paying the balance.
All-inclusive pricing with no separate membership, HSA/FSA accepted, free shipping in under three days, and it names the entity that actually prescribes.
The most completely specified offer in this research — dose-by-dose pricing, a stated lab cost, a smart scale, and Medicare plus most PPOs accepted.
Runs both routes properly — brand-name as low as $25 with insurance, or compounded semaglutide at $151 without — with a coordination team working the coverage.
An AI-first service at $39 a visit with no subscription that accepts all insurance — and states plainly that the AI is not a doctor.
Brand-name only, in stock, and priced at full retail — $1,199 to $1,599 a month with everything bundled in.
Carries FDA-approved Zepbound in both pens and vials alongside compounded and microdosed options — and refunds in full if you are not approved.
Oral semaglutide, compounded with an anti-nausea drug built in — and it runs your prior authorisation for the brand-name alternative.
Nurse-practitioner-led compounded GLP-1 care with a $100 first-month discount — and almost nothing else published.
A prescriber-only compounding pharmacy that, unlike Empower, does not state whether it operates as 503A or 503B.
Obesity-medicine specialists covered by national insurance including Medicare — one of very few services here that takes Medicare at all.
In-person and virtual weight-inclusive primary care with no membership dues — and a named Medicare Bridge GLP-1 programme.
From $199 a month with 1:1 video coaching, sold heavily through employers — and quoting results over three years rather than one.
Free at the point of use when your employer covers it — a support wrapper around GLP-1 care rather than a prescriber.
Lab-led rather than prescription-led: $65 for a 50-biomarker panel and consult, then $25 or $155 a month plus medication.
Compounded GLP-1s on a self-pay basis with clearly written cancellation terms — and no prices anywhere.
A medspa selling compounded tirzepatide alongside Botox and fillers, with a $259 monthly membership and promotional pricing.
An obesity-medicine certified physician and a ten-state telehealth footprint — and virtually no published terms.
Brand-name only at £164–£199 a month, GPhC-registered prescribers, and a 25-day money-back guarantee.
From £59 a month with a mandatory blood test included free — and a refund if the bloods say you are not eligible.
Brand-name Mounjaro and Wegovy with every prescription issued by a registered UK clinician — and a £20 headline that applies to a 90-day plan.
The full UK brand-name range including Foundayo, each listed with a headline weight-loss percentage — and no prices at all.
Free on the NHS by GP referral — the only route in this entire research where an eligible patient pays nothing.
CQC-regulated and free through NHS Right to Choose — a referral route most patients do not know exists.
Operating across eight European countries with a 30-day money-back guarantee — and almost nothing else published.
The most complete brand-name range we found, with lab work built in and a results guarantee — but government insurance disqualifies you entirely.
Publishes batch-testing detail almost nobody else does — and received an FDA warning letter in September 2025 over its marketing claims.
A complete price ladder across four plan lengths — $139 to $209 a month depending only on how far ahead you commit.
Compounded semaglutide with free discreet shipping and a physician review — and no published price.
Every dose of both major drugs priced individually — the most complete price ladder published by any provider in this research, in either market.
The only provider in this research that publishes BMI eligibility thresholds for every medication it sells.
A full UK price list including Nevolat and Foundayo, with stock status shown per product and same-day dispatch.
Publishes the full five-week titration schedule alongside the price — clinical detail almost no commercial page bothers with.
A high-street name with a named clinical lead and 24-hour click-and-collect — the shortest route from prescription to pen in this research.
CQC-regulated, doctor-led, with the full range priced including Foundayo — and a three-minute assessment gating it.
Dispenses through a network of over 100 partner pharmacies with free delivery over £50 — and publishes no prices.
Splits its range into injections and tablets with an efficacy figure on each — “up to 22%” and “up to 12.4%” — and no prices.
A GMC-registered consultant endocrinologist reviewing every assessment, published BMI criteria and an age range — the strongest clinical gate in the UK set.
The widest priced range in the UK — including Saxenda at £399 and a Foundayo listing showing £0.00, which is plainly an error.
GPhC-registered prescribers, competitive pricing, and free needles and a sharps bin with every injectable order.
Free consultation with UK-registered clinicians and no appointment needed — and a landing page that names neither medications nor prices.
A UK pharmacy that sells weight-loss medication but stocks no GLP-1 at all — which is itself worth knowing.
The supply side rather than the sales side — a 503A compounding pharmacy that publishes exact vial concentrations and will not sell to you directly.
Microdosing at $129 a month with ongoing dose adjustments — and no statement anywhere about whether the medication is compounded.
The only service here that does not prescribe GLP-1s at all — and positions itself explicitly as the offramp from them.
A provider marketplace that takes insurance and HSA/FSA, and states up front that a prescription is not guaranteed.
A behaviour-change company selling microdosed compounded GLP-1s in a single bundled price — and one of only two services here to confirm HSA and FSA cards work.
Flat-rate compounded semaglutide from $99/month — the same price at every dose — alongside sermorelin, NAD+ and its own supplement line, from a provider that names no pharmacy.
Microdosed compounded GLP-1s from $99 a month with no separate membership, free shipping, and a cancellation window tied to the next shipment.
A flat $75 consultation with no membership and an unusually broad medication list — including Saxenda, which almost nobody else still offers.
A cardiometabolic care service sold mainly through employers and health plans, with at-home lab testing built in and no consumer pricing published.
Two separate charges, both published in full — and a membership price that swings from $74 to $149 a month depending on how far ahead you are willing to pay.
Brand-name GLP-1s at competitive medication prices, sitting behind a $149/month membership that is billed separately and guarantees nothing.
A $49 clinician visit with no subscription at all, brand-name only, and you can send the prescription to any pharmacy you like — not just theirs.
The cheapest clinician visit we verified at $29, no membership, and same-day pickup at 9,000 pharmacies with pharmacist support included.
One of the few cash-pay platforms genuinely in-network with major insurers, and the only one that publishes what brand-name GLP-1s cost through it.
Board-certified primary care physicians, in-network with major insurers, and the only service in this research that says lab work is often required.
The cheapest verified total in this research — $139/month all-in for compounded semaglutide — with unlimited physician access included and cancel-anytime terms.
Publishes the unsubsidised cash price of brand-name GLP-1s — $1,000–$1,300 a month — and leans hard on cheap oral alternatives instead.
Primary care, pharmacy and virtual visits under one roof, taking most major insurance — and no membership required to start.
Brand-name Zepbound at a $99/month headline with fast turnaround — and almost nothing published about fees, insurance, or cancellation.
The search sweep surfaced these repeatedly, but every one of them blocked automated retrieval of its own pages, including through their corporate newsrooms. With no primary source to check against, there was nothing to review — a search fragment is not enough to write against, and assembling a review out of one would be inventing it. Where the index does carry text from the provider’s own page it is reproduced below, clearly marked as an unverified fragment rather than a finding.
| Provider | Sweep hits | Why it is not reviewed | What the index carries |
|---|---|---|---|
| GoodRx ↗ | 23 | The most frequently surfaced domain in the entire sweep, and the only one we could not reach by any route. Its own pages returned 403, its investor newsroom timed out twice, and the Wayback Machine holds no snapshot of the service page since January 2026 — seven months stale, and useless for current pricing. | “$39/mo. to start your weight loss treatment. Membership fee of $39/month applies and does not include medication cost. Price increases to $399 for 5mg doses…” |
| Eden ↗ | 3 | Direct retrieval returned 403. The most recent Wayback snapshot, 23 May 2026, is three months stale and carries almost no GLP-1 detail — the page is largely a general wellness catalogue. Not enough to review against. | “Personalized GLP-1 Treatments From $129 first month* *First month discount on 3-month plan”, alongside “$80 off your first GLP-1 Treatment Plan” and “Free expedited shipping on all orders” (archived 23 May 2026). |